JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Jason D souza as Other of the company w.e.f. March 06, 2026.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed the exchange about the resignation of three senior management personnel effective March 5-6, 2026. Mr. Kunal Khanna (President – Operations) and Mr. Dilip Singh Rathore (President – India Business) ceased to be associated with the company from the close of business hours on March 5, 2026. Mr. Jason D'souza (Executive Vice President) stepped down from the close of business hours on March 6, 2026. The resignations were made under Regulation 30 of SEBI LODR, and the resignation letters have been enclosed with the disclosure. No reasons for the exits have been stated in the filing.
The simultaneous departure of three senior leaders spanning operations and the India business raises short-term execution and continuity concerns, though no reasons have been disclosed. Shareholders should look for clarity on succession plans and whether this signals any deeper strategic or organizational change at the company.